LCTX

LINEAGE CELL THERAPEUTICS INC

Healthcare | Small Cap

-$0.02

EPS Forecast

$3.72

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.02

Revenue Forecast:

$3.72

EPS Surprise Forecast:

$0.002

Revenue Surprise Forecast:

$1

Post-release price volatility - High

Post-release Overnight Move:

±9.5%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

58%

Probability of beating revenue consensus:

67%

Probability of beating both EPS & revs consensus:

44%

Probability of missing both EPS & revs consensus:

20%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

0

Beta (β)

Forward Looking Beta (β):

1.13

Earnings volatility

EPS standard deviation:

$0.03

Revenue standard deviation:

$3

As % of share price:

1.74% HIGH

As % of market cap:

0.82% MEDIUM

Confidence intervals and percentiles

EPS 95th %ile:

$0.01

Revenue 95th %ile:

$7

EPS 75th %ile:

-$0.01

Revenue 75th %ile:

$5

EPS 25th %ile:

-$0.03

Revenue 25th %ile:

$3

EPS 5th %ile:

-$0.05

Revenue 5th %ile:

$1

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

40% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

84% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$100

Bid-ask per Share:

$0.015